Login / Signup

Rheumatic adverse events of immune checkpoint inhibitors in cancer immunotherapy.

Noha Abdel-WahabMaria E Suarez-Almazor
Published in: Expert review of clinical immunology (2024)
In light of the evolving landscape of cancer immunotherapy, there is a compelling need for prospective longitudinal studies to enhance understanding and inform clinical management strategies for rheumatic irAEs.
Keyphrases
  • rheumatoid arthritis
  • single cell
  • case control